For the latest COVID-19 campus news and resources, visit

Search Close Search
Search Close Search
Master of Science in Clinical Investigation Program
Page Menu

Master of Science in Clinical Investigation

Program Director: Dr. Robert Goldberg 

Program Overview

The Master of Science Degree in Clinical Investigation (MSCI) Program emphasizes the development of strong clinical investigation skills based on a solid foundation in study design, conduct of observational studies and randomized trials, clinical epidemiology, and biostatistics. Students acquire excellent writing and oral presentation skills through formal classroom work as well as by participating in several oral presentations. 

Trainees completing the MSCI Program acquire the necessary skills to successfully

  • Design, conduct, and analyze the results of clinical investigations at the individual and population-wide level. 
  • Design and analyze the results of studies that provide insights into the molecular pathophysiology of disease.

Trainees are grounded in the principles of clinical investigation with a flexible multidisciplinary focus providing curriculum tailored to their needs and interests as young researchers aspiring to become successful independent clinical investigators. 

Our clinical investigation research program is primarily intended for individuals already trained in the medical sciences as well as others with relevant scientific backgrounds and experiences who desire further training in research design and methodology. This includes physicians, nurses, dentists, medical students, and other health care professionals. 


The MSCI Program offers two concentration tracks:

  1. Population based clinical research 
  2. Bench-to -bedside translational research

These concentrations allow students to enhance their knowledge based on their current interests and career objectives. The participating faculty, representing the interdisciplinary nature of our MSCI Program, come from the disciplines of epidemiology, biostatistics, clinical research, biomedical informatics, molecular medicine, genomics, advanced therapeutics technologies, and drug development.